VIVO [NASD]
Meridian Bioscience, Inc.
Index- P/E21.51 EPS (ttm)1.41 Insider Own0.60% Shs Outstand43.55M Perf Week2.01%
Market Cap1.32B Forward P/E28.70 EPS next Y1.06 Insider Trans-37.45% Shs Float42.89M Perf Month10.62%
Income62.40M PEG1.27 EPS next Q0.19 Inst Own- Short Float5.83% Perf Quarter15.53%
Sales339.30M P/S3.88 EPS this Y51.70% Inst Trans4.26% Short Ratio6.29 Perf Half Y52.25%
Book/sh8.60 P/B3.54 EPS next Y-24.01% ROA13.70% Target Price30.00 Perf Year37.15%
Cash/sh1.77 P/C17.22 EPS next 5Y17.00% ROE18.20% 52W Range17.04 - 31.93 Perf YTD49.12%
Dividend- P/FCF16.11 EPS past 5Y16.40% ROI19.30% 52W High-3.51% Beta0.28
Dividend %- Quick Ratio2.60 Sales past 5Y10.10% Gross Margin58.80% 52W Low80.81% ATR1.18
Employees765 Current Ratio3.90 Sales Q/Q30.40% Oper. Margin23.70% RSI (14)62.41 Volatility4.61% 4.02%
OptionableYes Debt/Eq0.07 EPS Q/Q9.00% Profit Margin18.40% Rel Volume0.53 Prev Close30.42
ShortableYes LT Debt/Eq0.07 EarningsMay 06 BMO Payout0.00% Avg Volume397.68K Price30.81
Recom1.50 SMA207.58% SMA5014.14% SMA20033.61% Volume189,225 Change1.28%
Aug-11-20Resumed Piper Sandler Overweight $24
Jul-27-20Initiated H.C. Wainwright Buy $34
May-11-20Upgrade William Blair Mkt Perform → Outperform
May-01-19Upgrade Piper Jaffray Underweight → Neutral $15 → $11
Apr-03-19Downgrade Canaccord Genuity Hold → Sell $17 → $11
Jan-26-18Reiterated Canaccord Genuity Hold $14 → $16
Mar-28-17Initiated CL King Neutral
Mar-28-16Reiterated Canaccord Genuity Hold $18 → $19
Sep-10-15Reiterated Canaccord Genuity Hold $19 → $18
Jul-27-15Reiterated Canaccord Genuity Hold $20 → $19
May-04-15Reiterated Canaccord Genuity Hold $19 → $20
Nov-06-14Downgrade Robert W. Baird Outperform → Neutral $22 → $22
Jul-27-12Downgrade Canaccord Genuity Buy → Hold
Apr-25-11Upgrade Wedbush Underperform → Neutral $18 → $22
Mar-24-11Upgrade Canaccord Genuity Hold → Buy $30
Nov-16-10Initiated Canaccord Genuity Hold $21
Apr-07-10Initiated Wedbush Underperform $18
Nov-13-09Reiterated Caris & Company Average $21 → $20
Jul-07-09Initiated Caris & Company Average $21
Mar-06-09Initiated William Blair Mkt Perform
Jul-01-22 09:29AM  
Jun-20-22 08:38AM  
04:49AM  
Jun-16-22 09:02AM  
May-27-22 12:14PM  
May-26-22 01:31PM  
May-23-22 01:13PM  
May-17-22 03:33PM  
07:47AM  
May-06-22 03:10PM  
09:15AM  
08:00AM  
May-05-22 09:40AM  
09:12AM  
09:00AM  
08:50AM  
May-03-22 10:47AM  
06:37AM  
06:35AM  
May-02-22 10:01AM  
08:47AM  
08:25AM  
Apr-29-22 03:00PM  
12:10PM  
Apr-27-22 11:37AM  
11:01AM  
10:25AM  
09:05AM  
09:01AM  
Apr-26-22 12:34PM  
11:48AM  
09:56AM  
Apr-25-22 12:55PM  
08:38AM  
Apr-07-22 08:35AM  
08:06AM  
Apr-06-22 08:50AM  
08:45AM  
Mar-31-22 07:57AM  
Mar-29-22 02:37PM  
Mar-25-22 07:43AM  
Mar-24-22 08:03AM  
Mar-23-22 06:53AM  
Mar-21-22 07:49AM  
05:20AM  
Mar-15-22 11:07AM  
Mar-01-22 04:51PM  
Feb-21-22 09:00AM  
Feb-16-22 09:05AM  
Feb-10-22 11:50AM  
Feb-08-22 12:20PM  
Feb-04-22 11:30AM  
09:15AM  
08:00AM  
Feb-01-22 01:38PM  
Jan-31-22 11:45AM  
09:38AM  
Jan-28-22 03:00PM  
10:05AM  
06:23AM  
Jan-27-22 02:05PM  
Jan-11-22 01:03PM  
Jan-10-22 10:05AM  
Jan-05-22 10:15AM  
Jan-04-22 02:00PM  
Dec-22-21 09:59AM  
Dec-07-21 11:38AM  
Dec-02-21 08:00AM  
Nov-24-21 09:05AM  
Nov-17-21 10:05AM  
Nov-12-21 01:30PM  
11:45AM  
07:30AM  
Nov-10-21 08:55AM  
Nov-05-21 03:00PM  
Oct-27-21 10:05AM  
Oct-14-21 02:05PM  
Oct-07-21 02:00PM  
Oct-01-21 12:59PM  
Sep-09-21 10:00AM  
Sep-07-21 10:00AM  
Sep-02-21 07:58AM  
Sep-01-21 04:30PM  
Aug-30-21 02:00PM  
Aug-27-21 10:15AM  
Aug-26-21 11:57AM  
Aug-06-21 03:31PM  
09:15AM  
08:00AM  
Aug-02-21 09:00AM  
Jul-30-21 03:00PM  
12:24PM  
Jul-23-21 10:39AM  
09:20AM  
Jul-21-21 09:31AM  
Jul-14-21 09:00AM  
Jul-13-21 09:00AM  
Jul-09-21 05:45PM  
Jul-01-21 05:45PM  
Jun-28-21 09:25AM  
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kenny John P.Chief Executive OfficerJun 27Option Exercise10.1061,437620,514326,568Jun 28 09:42 AM
Kenny John P.Chief Executive OfficerJun 27Sale30.3961,4371,866,788265,131Jun 28 09:42 AM
Kenny John P.Chief Executive OfficerJun 24Option Exercise10.1013,559136,946278,690Jun 28 09:42 AM
Kenny John P.Chief Executive OfficerJun 24Sale30.0013,559406,836265,131Jun 28 09:42 AM
Kenny John P.Chief Executive OfficerJun 23Option Exercise11.2819,956225,091285,087Jun 24 12:33 PM
Kenny John P.Chief Executive OfficerJun 23Sale29.9819,956598,209265,131Jun 24 12:33 PM
Kenny John P.Chief Executive OfficerJun 22Option Exercise14.5044,651647,440309,782Jun 24 12:33 PM
Kenny John P.Chief Executive OfficerJun 22Sale29.7244,6511,326,921265,131Jun 24 12:33 PM
Kitzmiller Andrew S.EVP & CFOFeb 25Buy24.874,028100,16611,528Feb 28 02:40 PM
WELTZIEN LOURDESEVP, Life ScienceFeb 15Option Exercise14.5220,000290,375103,048Feb 17 11:22 AM
WELTZIEN LOURDESEVP, Life ScienceFeb 15Sale25.6020,000511,91283,048Feb 17 11:22 AM
PHILLIPS DAVIDDirectorJan 12Option Exercise18.547,500139,05014,045Jan 14 08:09 AM